181 related articles for article (PubMed ID: 25926402)
1. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis.
Kuzu UB; Öztaş E; Turhan N; Saygili F; Suna N; Yildiz H; Kaplan M; Akpinar MY; Akdoğan M; Kaçar S; Kiliç ZM; Köksal AŞ; Ödemiş B; Kayaçetin E
Hepatol Res; 2016 Apr; 46(4):277-91. PubMed ID: 25926402
[TBL] [Abstract][Full Text] [Related]
2. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
3. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
4. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
7. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
8. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.
Castiella A; Zapata E; Lucena MI; Andrade RJ
World J Hepatol; 2014 Apr; 6(4):160-8. PubMed ID: 24799984
[TBL] [Abstract][Full Text] [Related]
10. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
13. Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases.
Febres-Aldana CA; Alghamdi S; Krishnamurthy K; Poppiti RJ
J Clin Transl Hepatol; 2019 Mar; 7(1):21-26. PubMed ID: 30944815
[No Abstract] [Full Text] [Related]
14. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update.
Björnsson ES
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675480
[TBL] [Abstract][Full Text] [Related]
15. Histopathological analysis of autoimmune hepatitis with "acute" presentation: Differentiation from drug-induced liver injury.
Tsutsui A; Harada K; Tsuneyama K; Nguyen Canh H; Ando M; Nakamura S; Mizobuchi K; Baba N; Senoh T; Nagano T; Shibata H; Aoki T; Takaguchi K
Hepatol Res; 2020 Sep; 50(9):1047-1061. PubMed ID: 32515851
[TBL] [Abstract][Full Text] [Related]
16. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
17. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
18. Drug Liver Injury Induced by Olmesartan Mediated by Autoimmune-Like Mechanism: A Case Report.
de la Torre-Aláez M; Iñarrairaegui M
Eur J Case Rep Intern Med; 2020; 7(1):001407. PubMed ID: 32015975
[TBL] [Abstract][Full Text] [Related]
19. Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review.
Björnsson ES; Vucic V; Stirnimann G; Robles-Díaz M
Front Pharmacol; 2022; 13():820724. PubMed ID: 35222034
[No Abstract] [Full Text] [Related]
20. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
